AstraZeneca pausing coronavirus vaccine trial after neurological symptoms found

A study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent.

This entry was posted in Main. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *